Skip to main content
Clinical Trials/NL-OMON41596
NL-OMON41596CompletedNot Applicable

Immunomodulatory effects of Inulin-type fructans in a hepatitis B vaccination study - Inulin-type fructans and immune modulation

niversitair Medisch Centrum Groningen0 sites48 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
48

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Age 18-35 yr.
  • Healthy subjects
  • Male and female subjects
  • Caucasian subjects
  • Subjects enrolled to be vaccinated against Hepatitis B
  • Written informed consent
  • Dutch speaking subjects, i.e. subjects understanding spoken and written Dutch language

Exclusion Criteria

  • Presence of acute or chronic diseases
  • Gastrointestinal disorders (e.g. inflammatory bowel disease, celiac disease)
  • Gastrointestinal surgery
  • Treatment with antibiotics within 6 months of the start of the study
  • Prior vaccination with hepatitis B
  • Previous hepatitis B infection
  • Immunodeficiencies
  • Use of anti-coagulant drugs

Investigators

Similar Trials